A simple brush could spot mouth cancer early in fanconi anaemia patients
NCT ID NCT07242261
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
People with Fanconi anaemia have a high risk of developing oral cancer, but standard biopsies are painful and risky due to their genetic sensitivity. This study tests a non-invasive oral brushing technique to detect early cancer cells in 115 patients aged 15 and older. If accurate, this method could allow for easier, more frequent monitoring and earlier diagnosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- oral brushing
- What this could lead to
- If successful, this gentle brushing method could replace painful biopsies for detecting early oral cancer in Fanconi anaemia patients, enabling earlier diagnosis.
- What could go wrong
- This is an early-stage diagnostic study, not a treatment. The brushing method may not be as accurate as a biopsy, and results need confirmation in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FANCONI ANAEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single drink reveal how alcohol triggers oral cancer?
- Gene therapy aims to fix bone marrow failure in fanconi anemia
- New transplant method aims to reduce complications in bone marrow failure patients
- New MRI method could spot oral cancer early in rare disease patients
- New hope for rare cancer: targeted drug afatinib tested in fanconi anemia patients
- New drug combo aims to make bone marrow transplants safer for kids